Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2023 Publisher: hameln pharma ltd, Nexus, Gloucester Business Park, Gloucester, GL3 4AG, United Kingdom
Oxycodone Hydrochloride 50 mg/ml solution for injection or infusion.
| Pharmaceutical Form |
|---|
|
Solution for injection or infusion. Clear colourless solution, practically free from visible particles. |
Each 1 ml ampoule contains 50 mg oxycodone hydrochloride (equivalent to 45 mg oxycodone).
Excipients with known effect: This medicinal product contains less than 1 mmol sodium (23 mg) per 1 ml, that is to say essentially ‘sodium-free’.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Oxycodone |
Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative. |
| List of Excipients |
|---|
|
Citric acid monohydrate |
Colourless glass ampoules with a nominal volume of 1 ml.
Pack size: 5, 10 ampoules.
Not all pack sizes may be marketed.
hameln pharma ltd, Nexus, Gloucester Business Park, Gloucester, GL3 4AG, United Kingdom
PL 01502/0127
01/06/2018
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
